Jiabo Li
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.
Journal: Cellular signalling
Published: August 08, 2023
TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling.
Journal: Molecular and cellular biochemistry
Published: August 03, 2023
A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma.
Journal: Frontiers in oncology
Published: March 16, 2022
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma.
Journal: Cancer gene therapy
Published: February 17, 2022
Spinal epidural angiolipoma with a special pattern of calcification misdiagnosed as meningioma.
Journal: Acta neurologica Belgica
Published: December 17, 2021
TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.
Journal: Cancer gene therapy
Published: July 19, 2021
RAB1A regulates glioma cellular proliferation and invasion via the mTOR signaling pathway and epithelial-mesenchymal transition.
Journal: Future oncology (London, England)
Published: May 05, 2021
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Journal: Theranostics
Published: October 25, 2019
IGFBP2: integrative hub of developmental and oncogenic signaling network.
Journal: Oncogene
Published: October 06, 2019
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.
Journal: Cancer gene therapy
Published: June 25, 2019
Last Updated: 09/26/2026